Table 3.
Depression treatment history (N=868)* |
Beck Depression Inventory≥10 (N=654)* |
Antidepressant use (N=868)* |
||||
---|---|---|---|---|---|---|
Yes (n = 228) | No (n = 640) | Yes (n = 292) | No (n = 362) | Yes (n = 166) | No (n = 702) | |
No significant CAD† (mean, 95% confidence interval) | $29,300 ($21,603–$36,996) | $16,179 ($11,421–$20,938) | $25,771 ($20,016–$31,525) | $16,528 ($11,454–$21,601) | $34,716 ($25,439–$44,000) | $16,357 ($11,901–$20,814) |
| ||||||
Significant CAD (mean, 95% confidence interval) | $51,227 ($39,585–$62,868) | $38,516 ($32,864–$44,168) | $41,862 ($32,616–$51,109) | $33,932 ($25,396–$42,468) | $43,567 ($30,977–$56,159) | $40,380 ($34,885–$45,875) |
Significant CAD was defined as the presence of at least one coronary occlusion ≥50% from the participant’s coronary angiogram results.
Differences between depressed and non-depressed participants were statistically reliable at p<.05 among those with no evidence of significant CAD. Statistical tests were completed using log transformations of the table data to adjust for variable skewing.